Pfizer Inc.

NYSE:PFE   3:59:58 PM EDT
43.96
+1.15 (+2.69%)
4:43:42 PM EDT: $44.03 +0.07 (+0.16%)
Products

Pfizer Issues A Voluntary Nationwide Recall For Twelve Lots Of Chantix® (Varenicline) Tablets Due To N-Nitroso Varenicline Content

Published: 07/19/2021 18:40 GMT
Pfizer Inc. (PFE) - Pfizer Issues a Voluntary Nationwide Recall for Twelve Lots of Chantix® (varenicline) Tablets Due to N-nitroso Varenicline Content.
FDA Says to Date, Pfizer Has Not Received Any Reports of Adverse Events That Have Been Related to Recall.
FDA Says Pfizer Inc Believes the Benefit/risk Profile of Chantix Remains Positive.
FDA Says There is No Immediate Risk to Patients Taking Chantix.
FDA Says Pfizer Has Notified Their Direct Consignees by Letter to Arrange for Return of Any Recalled Product.
Further Company Coverage: Pfen ((reuters.
Briefs@thomsonreuters.
Com;)).